Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026
Milestone Pharmaceuticals, a biopharmaceutical company specializing in cardiovascular medicines, announced it will release its Q2 2026 financial results on August 12, followed by a business update and investor conference call. The company focuses on innovative treatments including its FDA-approved CARDAMYST nasal spray for certain heart arrhythmias…